alfimeprase: Clinical Trials

7 trials of alfimeprase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 terminated. 4 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Terminated 1
Phase 23Completed 2, Terminated 1

Follow alfimeprase: new trials by email Literature Review of alfimeprase trials Research Report on alfimeprase

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke
alfimeprase - Acute Ischemic Stroke
Phase 2TerminatedARCA Biopharma, Inc.72007-06-012008-04-24
Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery
alfimeprase - Arterial Occlusive Diseases
Phase 3TerminatedARCA Biopharma, Inc.3002006-04-012008-01-15
Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters
Alfimeprase - Thrombosis, Venous Thrombosis
Phase 3CompletedARCA Biopharma, Inc.2006-01-012008-08-15
Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters
Alfimeprase - Thrombosis, Venous Thrombosis
Phase 3CompletedARCA Biopharma, Inc.3002005-09-012008-08-14
Study of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery on Leg Arteries
alfimeprase - Arterial Occlusive Diseases
Phase 3CompletedARCA Biopharma, Inc.3002005-04-012008-01-15
Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion
Alfimeprase - Arterial Occlusive Diseases, Peripheral Vascular Diseases
Phase 2CompletedARCA Biopharma, Inc.1002003-06-012009-12-17
Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices
Alfimeprase - Catheters, Indwelling
Phase 2CompletedARCA Biopharma, Inc.1152010-02-03

Conditions studied

Thrombosis (7)  ·  Arterial Occlusive Diseases (3)  ·  Embolism (2)  ·  Intermittent Claudication (2)  ·  Thromboembolism (2)  ·  Venous Thrombosis (2)  ·  Ischemic Stroke (1)  ·  Peripheral Vascular Diseases (1)  ·  Stroke (1)

Sponsors

ARCA Biopharma, Inc. (7)

Countries

United States (7)  ·  Canada (1)

Top investigators

Mohammad Hirmand, MD (1)  ·  Steven Deitcher, M.D. (1)  ·  Steven R Deitcher, MD (1)  ·  Susan Begelman, M.D. (1)  ·  Susan M Begelman, MD (1)